3 Results for "

hypolipidemia

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "hypolipidemia" in MCE Product Catalog:

Cat. No.: HY-139040
CAS No.: 2921-20-2
Purity:  ≥98.0%
Target:  

PPAR

Research Areas:  

Metabolic Disease

2-Tetradecylthio acetic acid is a pan-peroxisome proliferator activated receptor (pan-PPAR) activator. 2-Tetradecylthio acetic acid induces hypolipidemia. 2-Tetradecylthio acetic acid reduces plasma lipids and enhances hepatic fatty acid oxidation in rodents. 2-Tetradecylthio acetic acid increases the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation .
loading...
    loading...
Cat. No.: HY-164082
CAS No.: 21340-68-1
Synonyms: Clofenapate methyl ester; MCP
Target:  

PPAR

Research Areas:  

Metabolic Disease Cancer

Methyl clofenapate (Clofenapate methyl ester; MCP) is a peroxisome proliferator, which can induce hypolipidemia, peroxisome proliferation, and hepatocarcinogenesis .
loading...
    loading...
Cat. No.: HY-139040R
CAS No.: 2921-20-2
Synonyms: Tetradecylthioacetic acid (Standard)
Research Areas:  

Metabolic Disease

2-(Tetradecylthio)acetic acid (Standard) is the analytical standard of 2-(Tetradecylthio)acetic acid. This product is intended for research and analytical applications. 2-Tetradecylthio acetic acid is a pan-peroxisome proliferator activated receptor (pan-PPAR) activator. 2-Tetradecylthio acetic acid induces hypolipidemia. 2-Tetradecylthio acetic acid reduces plasma lipids and enhances hepatic fatty acid oxidation in rodents. 2-Tetradecylthio acetic acid increases the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation .
loading...
    loading...